• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Authors » James Miessler

Articles by James Miessler

InspectionBusinessman-360x240.png

Inspection Essentials: Critical Factors to Consider When Prepping for an FDA Visit

December 5, 2022
James Miessler
FDA inspections can glide smoothly or run off the rails, depending on how thoroughly and thoughtfully sites and sponsors prepare for them. Before the agency shows up, consider 10 key factors to gauge your inspection readiness. Read More
CTA Clauses

Crucial CTA Clauses Must Be Phrased Carefully to Avoid Delays

December 1, 2022
James Miessler
The language in clinical trial agreements (CTA) must be very specific to avoid legal problems during the trial, but certain terms have the potential, if not handled correctly, to derail the negotiation process before the trial gets off the ground. Read More
Inspection-360x240.png

Post-BIMO Update, FDA Trial Inspections Heavy on Outsourcing Scrutiny

November 21, 2022
James Miessler
FDA inspections have been heavily focused on sponsor, CRO and site outsourcing activities since the Bioresearch Monitoring (BIMO) Program revised its manual for inspection processes in September 2021. Read More
FocusinRed-360x240.png

Revamp Organizational Structure to Focus on People, Not Performance, Expert Advises

November 14, 2022
James Miessler
With clinical research professionals exiting the industry in droves, it’s high time for research institutions to step back and assess themselves internally, evaluating how their own paradigms, cultures and priorities affect employees. Read More
RealWorldDataonWhiteBoard-360x240.png

FDA Looks for Relevance and Reliability of RWD Used in Clinical Trials, Experts Say

November 7, 2022
James Miessler
The FDA has signaled its support for the use of real-world data (RWD) — information gleaned from health records, patient registries and other sources — through pilot programs and guidances but has yet to set standards for the quality of that data, leaving sponsors, investigators and sites to find their own way to evaluate its relevance and reliability. Read More
key risk indicator - text

Centralized Monitoring Focuses on KRIs Sponsors Use to Evaluate Sites

November 1, 2022
James Miessler
At the intersection of risk-based quality management (RBQM) and performance metrics, sponsors are increasingly using centralized monitoring approaches to analyze data from sites that can predict risk and identify sites that may need additional support. Read More
Evaluation-360x240.png

Site Spotlight: St. Lawrence Health Evaluates Soft Skills to Hire Strong Candidates

October 31, 2022
James Miessler
Resumes and traditional interviews don’t always provide a complete and accurate picture of job candidates, as St. Lawrence Health System learned the hard way. Seeking a better view of potential hires, they’ve created a process that appraises soft skills and traits that can’t be adequately assessed through resumes and generic interview questions. Read More
Oncology-360x240.png

Phase 1 Oncology Trials Uniquely Challenging for Sites, Experts Say

October 31, 2022
James Miessler
Close sponsor contact, rapidly moving targets and timelines, unique facility and staff needs — these are only some of the factors that can make phase 1 trials more challenging for sites than the other phases, say several oncology research experts who offer advice for sites considering signing up for early-stage research. Read More
SocialMediaMarketing-360x240.png

Modern Day Marketing: Considerations for Advertising Trials on Social Media

October 24, 2022
James Miessler
Social media platforms are giving traditional television, print and radio advertising a run for their money, according to one marketing expert who says lower cost is not the only benefit of publicizing clinical trials on Facebook, Instagram, Twitter and Pinterest. Read More
DonationBoxes-360x240.png

Bayer’s Supply Donation Program Wins Top Spot in WCG’s First Innovation Challenge

October 24, 2022
James Miessler
Bayer’s efforts to make the charitable donation of unused trial kits and supplies an industrywide practice earned it the top spot at the inaugural WCG Innovation Challenge held at the MAGI Clinical Research Conference West in Las Vegas, Nev., last week. Read More
Previous 1 2 3 4 5 6 7 8 9 … 17 18 Next

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing